In the quest for a TBI therapy, astrocytes may be the bull’s-eye

Large-scale cancer genetic analysis in the Middle East paves way for precision prevention program
10 February 2022
Most vulnerable still in jeopardy as COVID precautions ease
10 February 2022

In the quest for a TBI therapy, astrocytes may be the bull’s-eye

Growing evidence suggests that traumatic brain injury (TBI) is an important risk factor for developing Alzheimer’s disease and dementia. But to date, effective therapies aren’t available for preventing or treating TBI-induced disease.

Comments are closed.